September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Nuclear receptor RORa regulates retinal inflammation and neovascularization in retinopathy through SOCS3
Author Affiliations & Notes
  • Chi-Hsiu Liu
    Department of Ophthalmology, Boston Children's Hospital, Boston, Massachusetts, United States
  • Ye Sun
    Department of Ophthalmology, Boston Children's Hospital, Boston, Massachusetts, United States
  • John Paul SanGiovanni
    National Institutes of Health, Bethesda, Maryland, United States
  • Lucy Evans
    Department of Ophthalmology, Boston Children's Hospital, Boston, Massachusetts, United States
  • Katherine Tian
    Department of Ophthalmology, Boston Children's Hospital, Boston, Massachusetts, United States
  • Andreas Stahl
    University of Freiburg, Freiburg, Germany
  • Theodore Kamenecka
    the Scripps Research Institute, Jupiter, Florida, United States
  • Laura Solt
    the Scripps Research Institute, Jupiter, Florida, United States
  • Jing Chen
    Department of Ophthalmology, Boston Children's Hospital, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Chi-Hsiu Liu, None; Ye Sun, None; John Paul SanGiovanni, None; Lucy Evans, None; Katherine Tian, None; Andreas Stahl, None; Theodore Kamenecka, None; Laura Solt, None; Jing Chen, None
  • Footnotes
    Support  NIH/NEI Grant R01 EY024963, Boston Children's Hospital (BCH) Career Development Award, BrightFocus Foundation and BCH Ophthalmology Foundation
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 3630. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Chi-Hsiu Liu, Ye Sun, John Paul SanGiovanni, Lucy Evans, Katherine Tian, Andreas Stahl, Theodore Kamenecka, Laura Solt, Jing Chen; Nuclear receptor RORa regulates retinal inflammation and neovascularization in retinopathy through SOCS3. Invest. Ophthalmol. Vis. Sci. 2016;57(12):3630.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Pathologic ocular neovascularization is a major cause of blindness, and linked with both dysregulated lipid metabolism and inflammation. Retinoic acid receptor-related orphan receptor alpha (RORa) is a lipid-sensing nuclear receptor regulating lipid metabolism and immunity in humans; genetic variations of RORa were associated with increasing risk of developing neovacular eye diseases. However the roles of RORa in influencing pathologic angiogenesis remains poorly understood.

Methods : A mouse model of oxygen-induced retinopathy (OIR) which mimics proliferative retinopathy was used. Neonatal mice were exposed to 75% O2 from postnatal day 7 to 12. RORa mRNA and protein levels were performed with OIR retinas compared with normoxic controls. Transcriptional target genes of RORa were analyzed by chromatin immunoprecipitation assay. Pathologic retinal vasoobliteration and neovascularization in OIR was quantified in RORa-deficient staggerer (Sg/Sg) and wild type (WT) mice, and WT mice treated with RORa inhibitors. Effects of modulating RORa in macrophages were analyzed in mouse RAW 264.7 cells in vitro.

Results : RORa expression was significantly increased in OIR mouse retinas, and localized in macrophages. Both genetic deficiency and pharmacologic inhibition of RORa substantially suppressed pathologic neovascularization in OIR, associated with decreased levels of pro-inflammatory cytokines and increased levels of anti-inflammatory cytokines. RORa transcriptionally controlled suppressors of cytokine signaling 3 (SOCS3), a critical negative regulator of inflammation. Suppression of SOCS3 diminished the pro-inflammatory effect of RORa in macrophages, and reverses macrophage RORa-mediated vascular growth ex vivo, and pathologic angiogenesis in vivo in retinopathy.

Conclusions : These findings demonstrate an important role of RORa in controlling retinal inflammation and pathologic neovascularization in proliferative retinopathy, through transcriptional modulation of SOCS3. RORa may represent a novel druggable target for treating retinopathy.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×